Hanson John M 4
4 · Talecris Biotherapeutics Holdings Corp. · Filed Apr 1, 2010
Insider Transaction Report
Form 4
Hanson John M
Executive VP & CFO
Transactions
- Tax Payment
Common Stock
2010-03-31$19.92/sh−13,928$277,446→ 85,691 total
Footnotes (1)
- [F1]The number of shares reported includes restricted share units representing the right to receive 17,763 shares of the Issuer's common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.